
April 5, 2013
AstraZeneca Takes Over AlphaCore – Analyst Blog
AstraZeneca 's ( AZN ) worldwide biologics research and development (R&D) unit, MedImmune recently acquired AlphaCore Pharma, a biotechnology company…
Notifications